期刊文献+

血管钠肽促进小鼠3T3-L1脂肪细胞合成脂联素及其可能机制 被引量:1

Vasonatrin peptide promotes the synthesis of adiponectin in 3T3-L1 adipocytes of mouse and the underlying mechanism
下载PDF
导出
摘要 目的探讨血管钠肽(VNP)对脂肪因子脂联素生成的影响及其机制。方法在3T3-L1细胞分化的脂肪细胞中加入不同浓度的VNP,分别用实时定量PCR法和Western blot法检测脂联素的mRNA水平和蛋白表达,放免法测定细胞内cGMP的水平。结果 VNP可显著增加脂联素mRNA水平和蛋白表达,同时提高细胞内cGMP,含量为(38±5)~(265±35)nmol/L,显著高于对照组的(10±2)nmol/L(P<0.01);该效应可用8-Br-cGMP诱导,可被cGMP依赖性蛋白激酶抑制剂KT-5823或钠尿肽受体NPR阻断剂HS-142-1抑制。结论 VNP可通过NPR/cGMP/PKG信号通路增加脂肪细胞脂联素的表达。 Objective To identify the roles of vasonatrin peptide (VNP) on adiponeetin ing mechanisms. Methods 3T3-L1 cells were differentiated into adipoeytes and exposed production and the underly- to various concentrations of VNP. Quantitative PCR and immunoassays were performed to determine the mRNA levels of adiponectin. Involved signaling pathway was identified by radioimmunoassay to detect the levels of intracellular cGMP[ (38 _ 5 ) - (265 ~ 35 )nmol/L ]. Results VNP markedly enhanced adiponectin mRNA expression as well as protein secretion. In ad- dition, VNP significantly enhanced the intracellular level of cGMP. The effects of VNP were mimicked by 8-Br- cGMP, whereas inhibited by HS-142-1 or KT-5823. Conclusions VNP regulates adiponectin production in adipo- cytes via a guanylyl cyclase-coupled NPR/cGMP/PKG pathway.
出处 《基础医学与临床》 CSCD 北大核心 2012年第9期1026-1029,共4页 Basic and Clinical Medicine
基金 国家"重大新药创制"科技重大专项(2009ZX09103) 国家自然科学基金(30870902 30801385 30800376) 陕西省自然科学基金(2010JM4050)
关键词 血管钠肽 钠尿肽 脂肪因子 脂联素 vasonatrin peptide natriuretic peptides adipokines adiponectin
  • 相关文献

参考文献14

  • 1Wei CM, Kim CH, Miller VM, et al. Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide [ J]. J Clin Invest, 1993, 92:2048 -2052.
  • 2Sengenes C, Zakaroff-Girard A, Moulin A, et al. Natriuret- ic peptide-dependent lipolysis in fat cells is a primate speci- ficity [ J]. Am J Physiol Regul Integr Comp Physiol, 2002, 283 : 257 - 265.
  • 3Nakatsuji H, Maeda N, Hibuse T, et al. Reciprocal regu- lation of natriuretic peptide receptors by insulin in adipose cells [ J]. Biochem Biophys Res Commun, 2010, 392: 100 - 105.
  • 4Nishikimi T, Iemura-Inaba C, Akimoto K, et al. Stimulato- ry and Inhibitory regulation of lipolysis by the NPR-A/ eGMP/PKG and NPR-C/G(i) pathways in rat cultured adi- pocytes [J]. Regul Pept, 2009, 153:56-63.
  • 5Sengenes C, Berlan M, De Glisezinski I, et al. Natriuretic peptides: a new lipolytie pathway in human adipocytes [J]. FASEBJ, 2000, 14:1345 -1351.
  • 6Tanaka T, Tsutamoto T, Sakai H, et al. Effect of atrial na- triuretic peptide on adiponectin in patients with heart failure [J]. Eur J Heart Fail, 2008, 10:360 -366.
  • 7张梅,李卫,冯鉴强.雌激素减轻H_2O_2诱导PC12细胞凋亡[J].基础医学与临床,2008,28(8):850-854. 被引量:5
  • 8Yu J, Feng HS, Chen BY, et al. Protecting effects of va- sonatrin peptide against hypobaric hypoxia-induced pulmo- nary hypertension in rats [ J]. Clin ExpPharmacol Physiol, 2010, 37 : 69 - 74.
  • 9Vachharajani V, Granger DN. Adipose tissue: a motor for the inflammation associated with obesity [J]. IUBMB Life, 2009, 61:424-430.
  • 10陈适,曾正陪,李汉忠,童安莉,卢琳,宋爱羚,李明.脂联素受体在人肾上腺皮髓质及其肿瘤中的不同表达[J].基础医学与临床,2011,31(2):134-138. 被引量:1

二级参考文献26

  • 1罗蔓,谢瑞满.雌激素减轻β-淀粉样蛋白所致PC12细胞毒活性的机制[J].中国老年保健医学,2006,4(3):33-36. 被引量:2
  • 2张雪晗,曾正陪,李汉忠,周亚茹,张晶,童安莉,阎朝丽.肾素-血管紧张素-醛固酮系统中不同组分在脂肪组织中的表达[J].中国医学科学院学报,2006,28(6):766-769. 被引量:10
  • 3王淑芳,赵家军,姜强,高聆,马慧.脂联素基因多态性与2型糖尿病相关性研究[J].中华内分泌代谢杂志,2007,23(1):51-52. 被引量:21
  • 4Vionnet N, Hani EH, Dupont S, et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24 [J]. Am J Hum Genet, 2000, 67: 1470-1480.
  • 5Liu Hekun, Chen Suyun, Zhang Sizhong, et al. Adiponectin gene variation -4522C/T is associated with type 2 dia- betic obesity and insulin resistance in Chinese[ J]. J Genet Genomics, 2007, 34 : 877 - 884.
  • 6Zietz B, Barth N, Scholmerich J, et al. Glyl5Gly polymorphism within the human adipocyte-specific apM-lgene but not Tyrl 11 His polymorphism is associated with higher levels of cholesterol and LDL-cholesterol in caucasian patients with type 2 diabetes [ J ]. Exp Clin Endocrinol Diabetes, 2001, 109 : 320 - 325.
  • 7Schwarz PE, Govindarajalu S, Towers W, et al. Haplotypes in the promoter region of the ADIPOQ gene are associated with increased diabetes risk in a German Caucasian population[J]. Horm Metab Res, 2006, 38:447-451.
  • 8Gu HF, Abulaiti A, Ostenson CG, et al. Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians[ J]. Diabetes, 2004, 53 Suppl 1 :S31 -35.
  • 9Vasseur F, Helbecque N, Lobbens S, et al. Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity[ J ]. Diabetologia, 2005, 48 : 892 - 899.
  • 10Vasseur F, Helbecque N, Dina C, et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians[J]. Hum Mol Genet, 2002, 11:2607-2614.

共引文献10

同被引文献5

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部